https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-is-nearing-a-record-again-as-it-enters-the-weight-loss-drugs-arena/
0
0
Stock Of The Day Lilly Nears A Record — Again — As It Enters The Obesity Arena - Investor's Business Daily
+ 13 more
11/20/23 at 7:41pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
Details
37 words
Summarize
Health Eli Lilly It Enters The Obesity Arena - Investor's Business Daily FDA Novo Nordisk
The FDA recently approved Eli Lilly's weight-loss drug, Zepbound, a rival to Novo Nordisk's Wegovy.
Create an account or login to join the discussion